Claims for Patent: 6,071,510

Summary for Patent: 6,071,510

Title:	Modified amino acids and compositions comprising the same for delivering active agents
Abstract:	The present invention provides modified amino acids for delivering active agents, and particularly biologically or chemically active agents. The preferred modified amino acids of the present invention include N-acylated or sulfonated amino acids. These modified amino acids are used as carriers to facilitate the delivery of a cargo to a target. Such modified amino acids are well suited to form non-covalent mixtures with biologically-active agents for oral administration to animals. Methods for the preparation and administration of the modified amino acids and compositions including the same are also provided.
Inventor(s):	Leone-Bay; Andrea (Ridgefield, CT), Ho; Koc-Kan (Mt. Kisco, NY), Press; Jeffery Bruce (Brewster, NY), Wang; Nai-Fang (Long Island, NY)
Assignee:	Emisphere Technologies, Inc. (Tarrytown, NY)
Application Number:	08/839,094
Patent Claims:	1. A compound selected from the group consisting of ##STR11## and salts thereof. 2. A poly amino acid comprising at least one residue derived from at least one compound selected from the group consisting of ##STR12## and salts thereof. 3. A poly amino acid as defined in claim 2, comprising a peptide. 4. A composition comprising (a) an active agent; and (b) a compound selected from the group consisting of ##STR13## and salts thereof. 5. A composition comprising (a) an active agent; and (b) a poly amino acid comprising at least one residue derived from an amino acid selected from the group consisting of ##STR14## and salts thereof. 6. A composition as defined in claim 5, wherein said poly amino acid comprises a peptide. 7. A composition as defined in claim 4, wherein said active agent is selected from the group consisting of a biologically active agent and a chemically active agent. 8. A composition as defined in claim 7, wherein said biologically active agent is selected from the group consisting of a peptide, a mucopolysaccharide, a carbohydrate, a lipid, a pesticide, and any combination thereof. 9. A composition as defined in claim 8, wherein said biologically active agent is selected from the group consisting of human growth hormone, bovine growth hormone, growth hormone-releasing hormone, an interferon, interleukin-II, insulin, heparin, calcitonin, erythropoietin, atrial naturetic factor, an antigen, a monoclonal antibody, somatostatin, adrenocorticotropin, gonadotropin releasing hormone, oxytocin, vasopressin, cromolyn sodium, vancomycin, desferrioxamine (DFO), and any combination thereof. 10. A composition as defined in claim 5, wherein said active agent is selected from the group consisting of a biologically active agent and a chemically active agent. 11. A composition as defined in claim 10, wherein said biologically active agent is selected from the group consisting of a peptide, a mucopolysaccharide, a carbohydrate, a lipid, a pesticide, and any combination thereof. 12. A composition as defined in claim 11, wherein said biologically active agent is selected from the group consisting of human growth hormone, bovine growth hormone, growth hormone-releasing hormone, an interferon, interleukin-II, insulin, heparin, calcitonin, erythropoietin, atrial naturetic factor, an antigen, a monoclonal antibody, somatostatin, adrenocorticotropin, gonadotropin releasing hormone, oxytocin, vasopressin, cromolyn sodium, vancomycin, desferrioxamine (DFO), and any combination thereof. 13. A composition as defined in claim 6, wherein said active agent is selected from the group consisting of a biologically active agent and a chemically active agent. 14. A composition as defined in claim 13, wherein said biologically-active agent is selected from the group consisting of a peptide, a mucopolysaccharide, a carbohydrate, a lipid, a pesticide, and any combination thereof. 15. A composition as defined in claim 14, wherein said biologically-active agent is selected from the group consisting of human growth hormone, bovine growth hormone, growth hormone-releasing hormone, an interferon, interleukin-II, insulin, heparin, calcitonin, erythropoietin, atrial naturetic factor, an antigen, a monoclonal antibody, somatostatin, adrenocorticotropin, gonadotropin releasing hormone, oxytocin, vasopressin, cromolyn sodium, vancomycin, desferrioxamine (DFO), and any combination thereof. 16. A dosage unit form comprising (A) a composition as defined in claim 4; and (B) (a) an excipient, (b) a diluent, (c) a disintegrant, (d) a lubricant, (e) a plasticizer, (f) a colorant, (g) a dosing vehicle, or (h) any combination thereof. 17. A dosage unit form according to claim 1 6, comprising a tablet, a capsule, or a liquid. 18. A dosage unit form comprising (A) a composition as defined in claim 5; and (B) (a) an excipient, (b) a diluent, (c) a disintegrant, (d) a lubricant, (e) a plasticizer, (f) a colorant, (g) a dosing vehicle, or (h) any combination thereof. 19. A dosage unit form according to claim 18, comprising a tablet, a capsule, or a liquid. 20. A dosage unit form comprising (A) a composition as defined in claim 6; and (B) (a) an excipient, (b) a diluent, (c) a disintegrant, (d) a lubricant, (e) a plasticizer, (f) a colorant, (g) a dosing vehicle, or (h) any combination thereof. 21. A dosage unit form according to claim 20, comprising a tablet, a capsule, or a liquid. 22. A method for administering a biologically-active agent to an animal in need of said agent, said method comprising administering orally to said animal a composition as defined in claim 4. 23. A method for administering a biologically-active agent to an animal in need of said agent, said method comprising administering orally to said animal a composition as defined in claim 5. 24. A method for administering a biologically-active agent to an animal in need of said agent, said method comprising administering orally to said animal a composition as defined in claim 6. 25. A method for preparing a composition, said method comprising mixing: (A) at least one biologically-active agent; (B) at least one compound as defined in claim 1; and (C) optionally a dosing vehicle. 26. A method for preparing a composition, said method comprising mixing: (A) at least one biologically-active agent; (B) at least one poly amino acid as defined in claim 2; and (C) optionally a dosing vehicle. 27. A method for preparing a composition, said method comprising mixing: (A) at least one biologically-active agent; (B) at least one peptide as defined in claim 3; and (C) optionally a dosing vehicle. 28. A method for preparing a compound having the formula ##STR15## wherein Y is ##STR16## R.sup.1 is C.sub.3 -C.sub.24 alkyl, C.sub.2 -C.sub.20 alkenyl, C.sub.2 -C.sub.20 alkyne, cycloalkyl, or aromatic; R.sup.2 is hydrogen, C.sub.1 -C.sub.4 alkyl, or C.sub.2 -C.sub.4 alkenyl; and R.sup.3 is C.sub.1 -C.sub.7 alkyl, C.sub.3 -C.sub.10 cycloalkyl, aryl, thienyl, pyrrolo, or pyridyl, where R.sup.3 is optionally substituted by one or more C.sub.1 -C.sub.5 alkyl group, C.sub.2 -C.sub.4 alkenyl group, F, Cl, OH, SO.sub.2, COOH and SO.sub.3 H; said method comprising (a) reacting in water and the presence of a base, a compound having the formula ##STR17## with a compound having the formula wherein Y, R.sup.1, R.sup.2, and R.sup.3 are as above and X is a leaving group. 29. A composition for oral delivery of a biologically active agent, said composition comprising (a) a biologically active agent; and (b) an oral delivery effective amount of at least one compound selected from the group consisting of ##STR18## a poly amino acid derived from at least one compound selected from the group consisting of compounds V, XXXI, and XXXIII, and salts thereof, wherein said biologically active agent comprises at least one peptide, mucopolysaccharide, carbohydrate, or lipid. 30. A composition as defined in claim 29, wherein said biologically active agent is selected from the group consisting of human growth hormone, bovine growth hormone, growth hormone-releasing hormone, an interferon, interleukin-II, insulin, heparin, low molecular weight heparin, calcitonin, erythropoietin, atrial naturetic factor, an antigen, a monoclonal antibody, somatostatin, adrenocorticotropin, gonadotropin releasing hormone, oxytocin, vasopressin, cromolyn sodium, vancomycin, parathyroid hormone, desferrioxamine (DFO), and any combination thereof.

Details for Patent 6,071,510

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015		2015-03-31